Search for Stocks Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Offers

BAJAJ FINSERV DIRECT LIMITED

Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Dr. Lal Pathlabs Ltd. Share Price

NSE

BSE

NSE : LALPATHLAB

BSE : 539524

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

empty graph

Price Summary

Previous Close	₹1,907.30
Day's Range	₹1,903.10 - ₹1,944.00
Open	₹1,920.40
52 Week Range	₹1,272.60 - ₹2,038.60
Volume	2,62,089
Market Cap	₹0.03

Previous Close	₹1,907.50
Day's Range	₹1,905.30 - ₹1,943.90
Open	₹1,926.35
52 Week Range	₹1,272.00 - ₹2,035.00
Volume	3,958
Market Cap	₹0.03

Stocks Summary

Trade Value ( ₹ in Lacs)	4,998.82
Market Cap (₹ in Mn)	0.03
Dividend Yield(%)	1.07
Price/Earning (TTM)	59.36
TTM EPS (₹)	32.28
P/E Ratio	43.61
Book Value(₹)	12.31
PAT Margin (%)	18.45
Face Value (₹)	10.00
ROCE(%)	29.56

Trade Value ( ₹ in Lacs)	75.50
Market Cap (₹ in Mn)	0.03
Dividend Yield(%)	1.07
Price/Earning (TTM)	59.36
TTM EPS (₹)	32.28
P/E Ratio	43.61
Book Value(₹)	12.31
PAT Margin (%)	18.45
Face Value (₹)	10.00
ROCE(%)	29.56

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	6698.0	23516.0
Expenses	N/A	N/A
PBT	1811.0	6213.0
Operating profit	0.0	0.0
Net profit	1340.0	4973.0

Shareholding Pattern

Promoters (% Holding)

53.19%

Mutual funds (% Holding)

18.79%

Non-Institution (% Holding)

7.99%

FI/Banks/Insurance (% Holding)

2.37%

Government (% Holding)

0.01%

FII

17.35%

About Dr. Lal Pathlabs Ltd.

Founded	1995
NSE Symbol	LALPATHLAB

Peer Comparision

Stocks Name	Market Cap (Cr)(₹)	Market Price (₹)	52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd.	4,48,195.77	1,844.00	1,548.00 - 1,548.00
Divi's Laboratories Ltd.	2,50,389.96	9,344.00	5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd.	1,88,966.75	4,991.00	3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd.	1,28,543.48	8,887.75	6,696.50 - 6,696.50
Lenskart Solutions Ltd.	1,18,933.76	692.20	0.00 - 0.00
Zydus Lifesciences Ltd.	1,15,860.07	1,161.00	835.50 - 835.50
Cipla Ltd.	1,11,888.39	1,378.00	1,165.70 - 1,165.70
Laurus Labs Ltd.	1,09,035.01	2,005.10	823.10 - 823.10
Max Healthcare Institute Ltd.	1,03,608.88	1,056.40	903.00 - 903.00
Mankind Pharma Ltd.	1,00,363.76	2,479.40	1,909.70 - 1,909.70

Latest News

Jul

2

2026

EQUITY Posted on Jul 2^nd 2026

Dr. Lal PathLabs informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has attached the copy of newspaper advertisement(s), published in Financial Express and Jansatta on July 02, 2026, intimating about the dispatch of Notice of 32nd Annual General Meeting and Annual Report for FY 2025-26 to the Members of the Company.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

22

2026

EQUITY Posted on Sep 22^nd 2026

Makers Laboratories informs about trading window closure

Makers Laboratories has informed that the trading window for dealing in the securities of the Company by the insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from 1st October, 2026 and until 48 hours after the declaration of the Company’s unaudited financial results for the 2nd quarter and half year ended 30th September, 2026 of the financial year 2026-27.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

22

2026

EQUITY Posted on Sep 22^nd 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Acquires 26% Stake in ₹300 Crore-Valued Goodman Vetcare Pvt. Ltd., One of India’s Longest-Standing Dedicated Pet Pharmacies’ issued by the company.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

22

2026

EQUITY Posted on Sep 22^nd 2026

Park Medi World informs about press release

Pursuant to Regulation 30 of the Listing Regulations, Park Medi World has informed that it enclosed Press Release titled ‘Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026’. The above disclosure is also being made available on the website of the Company at https://www.parkhospital.in/.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

21

2026

EQUITY Posted on Sep 21^st 2026

Haleos Labs informs about closure of trading window

Haleos Labs has informed that ‘Trading Window’ for dealing in securities of the Company for Designated Persons and specified Connected Persons (including their Immediate relatives) of the Company and Subsidiary of the Company, shall remain closed with effect from October 1, 2026 till 48 hours after the declaration of financial results for quarter and half year ended sept 30, 2026, In terms of the ‘Code of Conduct for Prevention of Insider Trading’ of the Company. Date of the Board meeting for considering the unaudited financial results Of the Company for the quarter and half year ended September 30, 2026, will be informed separately in due course.

The above information is a part of company’s filings submitted to BSE.

Read More

Sign in to Unlock Offers!

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Dr. Lal Pathlabs Ltd. ?

The current share price of Dr. Lal Pathlabs Ltd. is ₹1,907.30 as of 2026-09-22.

What is the Market Cap of Dr. Lal Pathlabs Ltd. Share?

The market capitalisation of Dr. Lal Pathlabs Ltd. is ₹32,164.87 as of 2026-09-21.

What is a 1 year return for Dr. Lal Pathlabs Ltd. ?

The 1-year return of Dr. Lal Pathlabs Ltd. is 170.55% as of 2026-09-22.

What is the P/E Ratio of Dr. Lal Pathlabs Ltd. Share?

The P/E ratio of Dr. Lal Pathlabs Ltd. is 43.61 as of 2026-09-22.

What is the 52 Week High and Low of Dr. Lal Pathlabs Ltd. ?

The 52-week high and low of Dr. Lal Pathlabs Ltd. are ₹2,038.60 and ₹1,272.60, respectively, as of 2026-09-22.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore